
ALT Find our scientific posters at #HIVGlasgow P011 Prevalence of HIV drug resistance in people newly diagnosed with HIV who have used pre‐exposure prophylaxis in Europe: the PrEPaRe study Presented by Marie Louise Jakobsen on behalf of the PrEPaRe study group. P272 Changes in the ART coverage and viral suppression from 2020 to 2022 in Kyiv, Ukraine Presented by Olga Fursa on behalf of the CARE study group. P307 Mortality and Non-fatal Clinical Outcomes After The Most Common Cancers in People With HIV: a Multicohort Collaboration Presented by Alisa Timiryasova on behalf of the RESPOND (International Cohort Consortium of Infectious Diseases) and D:A:D (The Data Collection on Adverse Events of Anti-HIV Drugs Study) study groups. P334 Mortality using raltegravir versus other integrase inhibitors in people with HIV in Europe and Australia Presented by Erich Tusch on behalf of the RESPOND (International Cohort Consortium of Infectious Diseases) study group.

ALT https://uni-koeln.zoom.us/meeting/register/tJEufuGsrjkpGdFZR-IAieAMk-NX77A4nSHI https://link.springer.com/article/10.1007/s15010-024-02347-1 https://portal.uni-koeln.de/en/universitaet/aktuell/press-releases/single-news/innovative-approach-to-vaccine-trials-and-pandemic-preparedness https://pubmed.ncbi.nlm.nih.gov/38992789/ https://vaccelerate.eu/eu-covat-1-aged/ https://www.theguardian.com/world/2024/apr/20/next-pandemic-likely-to-be-caused-by-flu-virus-scientists-warn https://www.youtube.com/watch?v=nhbz04dXYgc



























